This multicenter prospective trial assessed the outcome in 63 patients 40 years or younger with high-risk early breast cancer (HREBC) contained in an ovarian protection study. 26-40). Sixty-five percent got ER+ tumors 24 got harmful axillary nodes with tumors >1 cm and high histological quality with lymphovascular invasion while 76% got a mean of 3.6… Continue reading This multicenter prospective trial assessed the outcome in 63 patients 40